These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3245401)

  • 41. Absolute bioavailability of quinidine in two sustained release preparations.
    Amlie JP; Storstein L; Olsson B; Fremstad D; Jacobsen S
    Eur J Clin Pharmacol; 1979 Aug; 16(1):45-8. PubMed ID: 499299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative bioavailability study of three sustained release quinidine formulations.
    Mahon WA; Leeder JS; Brill-Edwards MM; Correia J; MacLeod SM
    Clin Pharmacokinet; 1987 Aug; 13(2):118-24. PubMed ID: 3621768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparative bioavailability of 2 oral theophylline sustained-release preparations].
    Tritthart W; Lücker PW; Fáy E; Buchebner J
    Arzneimittelforschung; 1983; 33(11):1603-6. PubMed ID: 6686457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Bioavailability of metoclopramide in a sustained-release preparation].
    Berner G; Leuschner F; Wagener HH; Becker A
    Arzneimittelforschung; 1984; 34(5):637-9. PubMed ID: 6540582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of fever on quinine and quinidine disposition in the rat.
    Mansor SM; Ward SA; Edwards G
    J Pharm Pharmacol; 1991 Oct; 43(10):705-8. PubMed ID: 1682445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The bioavailability and kinetics of dihydroquinidine in patients with heart disease.
    Regazzi Bonora M; Salerno JA; Rondanelli R; Cristiani D; Chimienti M
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):212-8. PubMed ID: 7095920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pharmacokinetics and relative bioavailability of a nitroglycerin ointment formulation (author's transl)].
    Maier-Lenz H; Ringwelski L; Windorfer A
    Arzneimittelforschung; 1980; 30(2):320-4. PubMed ID: 6769443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A method of determining the in vivo drug release rate constant of sustained-release preparation.
    Sun H; Chow MS
    Drug Metab Dispos; 1995 Apr; 23(4):449-54. PubMed ID: 7600910
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of quinidine plasma concentration curves following oral administration of some short- and long-acting formulations.
    Frigo GM; Perucca E; Teggia-Droghi M; Gatti G; Mussini A; Salerno J
    Br J Clin Pharmacol; 1977 Aug; 4(4):449-54. PubMed ID: 901736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The reproducibility of quinine bioavailability.
    Paintaud G; Alván G; Ericsson O
    Br J Clin Pharmacol; 1993 Mar; 35(3):305-7. PubMed ID: 8471408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparative bioavailability study on two sustained-release formulations of diclofenac sodium following a single dose administration.
    Hasan MM; Najib NM; Muti H
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):387-91. PubMed ID: 8225684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative in vitro-in vivo study of two quinine rectal gel formulations.
    Fawaz F; Koffi A; Guyot M; Millet P
    Int J Pharm; 2004 Aug; 280(1-2):151-62. PubMed ID: 15265555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative bioavailability of sustained-release and uncoated aspirin tablets.
    Karahalios WJ; Sawyer WT; Rittase RA; Maynard SA
    Am J Hosp Pharm; 1981 Nov; 38(11):1754-6. PubMed ID: 7304632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serious bioavailability problems with a generic prolonged-release quinidine gluconate product.
    Meyer MC; Straughn AB; Lieberman P; Jacob J
    J Clin Pharmacol; 1982; 22(2-3):131-4. PubMed ID: 7068936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO; Mellstrand T; Svedmyr N
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quinine impairs quinidine clearance in rat perfused liver.
    Mihaly GW; Scott H; Hyman MK; Morgan DJ; Smallwood RA
    J Pharm Pharmacol; 1993 Mar; 45(3):215-7. PubMed ID: 8097780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relative bioavailability of three commercial quinidine dosage forms.
    Sirois G; Eshaque M; Chabot M
    Biopharm Drug Dispos; 1980; 1(4):167-77. PubMed ID: 7448345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioavailability of metformin. Comparison of solution, rapidly dissolving tablet, and three sustained release products.
    Pentikäinen PJ
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):213-20. PubMed ID: 3710634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative bioavailability study of a generic sustained release diclofenac sodium tablet.
    Magosso E; Yuen KH; Choy WP; Ling SS; Ng BH; Ur-Rahman N; Wong JW
    Med J Malaysia; 2004 Aug; 59(3):352-6. PubMed ID: 15727381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.